Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1282493rdf:typepubmed:Citationlld:pubmed
pubmed-article:1282493lifeskim:mentionsumls-concept:C0036636lld:lifeskim
pubmed-article:1282493lifeskim:mentionsumls-concept:C0282580lld:lifeskim
pubmed-article:1282493lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:1282493lifeskim:mentionsumls-concept:C0003261lld:lifeskim
pubmed-article:1282493lifeskim:mentionsumls-concept:C0086597lld:lifeskim
pubmed-article:1282493lifeskim:mentionsumls-concept:C1704419lld:lifeskim
pubmed-article:1282493pubmed:issue3lld:pubmed
pubmed-article:1282493pubmed:dateCreated1993-2-10lld:pubmed
pubmed-article:1282493pubmed:abstractTextThe rational development of peptide vaccines requires the identification of both B- and T-cell epitopes. In this study, potential T-helper cell epitopes of Semliki Forest virus (SFV) were identified on the basis of their ability to induce delayed-type hypersensitivity (DTH) in mice using recombinant SFV fragments produced as hybrid proteins with beta-galactosidase in Escherichia coli and synthetic peptides coupled to beta-galactosidase. Although the tested fragments spanned almost the entire amino acid sequence of the structural proteins of SFV, only one DTH-inducing region (located between amino acid 137 and 151 of the SFV E2 membrane protein) was identified. Peptides containing this E2 region stimulated lymph node cells from SFV-primed mice in vitro. The ability of the identified T-cell epitope to induce a specific T-helper response in mice was evaluated using synthetic peptides that contained combinations of the DTH-inducing region and different previously identified linear B-cell epitopes of E2. These peptides proved able to induce an antipeptide IgG response in mice in an H-2d-restricted fashion. One of the peptides was also able to induce high titres of IgG reactive with SFV-infected cells and protected 70-100% of the peptide-immunized mice after challenge with virulent SFV. Our findings suggest that DTH and T-helper activity are mediated by different doses of the same T-cell epitope.lld:pubmed
pubmed-article:1282493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1282493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1282493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1282493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1282493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1282493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1282493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1282493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1282493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1282493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1282493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1282493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1282493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1282493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1282493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1282493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1282493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1282493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1282493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1282493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1282493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1282493pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1282493pubmed:languageenglld:pubmed
pubmed-article:1282493pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1282493pubmed:citationSubsetIMlld:pubmed
pubmed-article:1282493pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1282493pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1282493pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1282493pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1282493pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1282493pubmed:statusMEDLINElld:pubmed
pubmed-article:1282493pubmed:monthNovlld:pubmed
pubmed-article:1282493pubmed:issn0019-2805lld:pubmed
pubmed-article:1282493pubmed:authorpubmed-author:SnippeHHlld:pubmed
pubmed-article:1282493pubmed:authorpubmed-author:FernandesRRlld:pubmed
pubmed-article:1282493pubmed:authorpubmed-author:KraaijeveldC...lld:pubmed
pubmed-article:1282493pubmed:authorpubmed-author:SnijdersAAlld:pubmed
pubmed-article:1282493pubmed:authorpubmed-author:Benaissa-Trou...lld:pubmed
pubmed-article:1282493pubmed:authorpubmed-author:Visser-Vernoo...lld:pubmed
pubmed-article:1282493pubmed:issnTypePrintlld:pubmed
pubmed-article:1282493pubmed:volume77lld:pubmed
pubmed-article:1282493pubmed:ownerNLMlld:pubmed
pubmed-article:1282493pubmed:authorsCompleteYlld:pubmed
pubmed-article:1282493pubmed:pagination322-9lld:pubmed
pubmed-article:1282493pubmed:dateRevised2010-9-7lld:pubmed
pubmed-article:1282493pubmed:meshHeadingpubmed-meshheading:1282493-...lld:pubmed
pubmed-article:1282493pubmed:meshHeadingpubmed-meshheading:1282493-...lld:pubmed
pubmed-article:1282493pubmed:meshHeadingpubmed-meshheading:1282493-...lld:pubmed
pubmed-article:1282493pubmed:meshHeadingpubmed-meshheading:1282493-...lld:pubmed
pubmed-article:1282493pubmed:meshHeadingpubmed-meshheading:1282493-...lld:pubmed
pubmed-article:1282493pubmed:meshHeadingpubmed-meshheading:1282493-...lld:pubmed
pubmed-article:1282493pubmed:meshHeadingpubmed-meshheading:1282493-...lld:pubmed
pubmed-article:1282493pubmed:meshHeadingpubmed-meshheading:1282493-...lld:pubmed
pubmed-article:1282493pubmed:meshHeadingpubmed-meshheading:1282493-...lld:pubmed
pubmed-article:1282493pubmed:meshHeadingpubmed-meshheading:1282493-...lld:pubmed
pubmed-article:1282493pubmed:meshHeadingpubmed-meshheading:1282493-...lld:pubmed
pubmed-article:1282493pubmed:meshHeadingpubmed-meshheading:1282493-...lld:pubmed
pubmed-article:1282493pubmed:meshHeadingpubmed-meshheading:1282493-...lld:pubmed
pubmed-article:1282493pubmed:meshHeadingpubmed-meshheading:1282493-...lld:pubmed
pubmed-article:1282493pubmed:meshHeadingpubmed-meshheading:1282493-...lld:pubmed
pubmed-article:1282493pubmed:year1992lld:pubmed
pubmed-article:1282493pubmed:articleTitleA delayed-type hypersensitivity-inducing T-cell epitope of Semliki Forest virus mediates effective T-helper activity for antibody production.lld:pubmed
pubmed-article:1282493pubmed:affiliationEijkman-Winkler Laboratory of Medical Microbiology, Academic Hospital Utrecht, The Netherlands.lld:pubmed
pubmed-article:1282493pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1282493pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1282493lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1282493lld:pubmed